for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Unichem Laboratories Limited

UNLB.NS

Latest Trade

194.75INR

Change

6.20(+3.29%)

Volume

153,443

Today's Range

184.05

 - 

201.00

52 Week Range

160.15

 - 

228.00

As of on the National Stock Exchange of India ∙ Minimum 15 minute delay

Pricing

Previous Close
188.55
Open
187.00
Volume
153,443
3M AVG Volume
0.87
Today's High
201.00
Today's Low
184.05
52 Week High
228.00
52 Week Low
160.15
Shares Out (MIL)
70.41
Market Cap (MIL)
13,711.52
Forward P/E
--
Dividend (Yield %)
2.05

Latest Developments

More

Unichem Laboratories Says U.S. FDA's Inspection At Kolhapur Facility Ends Without Any Form 483 Issued

Unichem Laboratories Gets Receives ANDA Nod From USFDA For Solifenacin Succinate Tablets

India's Unichem Gets 1 Observation From USFDA Inspection Of Ghaziabad Unit

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Unichem Laboratories Limited

Unichem Laboratories Limited is a pharmaceutical company. The Company manufactures active pharmaceutical ingredients (APIs or bulk actives). In addition, it has various pharma products for addressing therapeutic areas, such as gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterials, anti-infectives and pain management. It provides a range of metabolic syndrome products for addressing diseases, such as hypertension, obesity, atherogenic dyslipidemia and prothrombosis. Its products address acne, immune mediated skin disorders, hereditary skin diseases and genodermatoses, among others. Its products treat rheumatic and orthopedic ailments. It offers an array of products that include anti-depressant, anti-psychotic, tranquilizer, cerebral activator, anti-platelet and neuropathic pain drugs. It has a range of formulation products for addressing ear-nose-throat (ENT)-related health problems. Its brands include Losar, TG Tor, Olsar, Tolol and Trika.

Industry

Major Drugs

Contact Info

Unichem Bhavan

Off S.V.Road, Prabhat Estate

Jogeshwari (West)

+91.22.66888333

https://www.unichemlabs.com/

Executive Leadership

Prakash Amrut Mody

Executive Chairman of the Board, Managing Director

Pradeep Bhandari

Chief Compliance Officer, Company Secretary

Rakesh Parikh

Vice President - Finance, IR Contact Officer

Dilip Kunkolienkar

Additional Whole - Time Director

Prafull Anubhai

Independent Non-Executive Director

Key Stats

Price To Earnings (TTM)
--
Price To Sales (TTM)
--
Price To Book (MRQ)
--
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
--
LT Debt To Equity (MRQ)
--
Return on Investment (TTM)
--
Return on Equity (TTM)
--

Latest News

BRIEF-Unichem Laboratories Gets ANDA Approval From U.S. FDA For Valsartan Tablets, USP

* SAYS GOT ANDA APPROVAL FROM USFDA FOR VALSARTAN TABLETS, USP

BRIEF-Unichem Laboratories Seeks Shareholders' Nod For Share Buyback Proposal

* SEEKS SHAREHOLDERS' NOD FOR SHARE BUYBACK PROPOSAL WORTH 8.86 BILLION RUPEES Source text - http://bit.ly/2mik1mO Further company coverage:

BRIEF-Unichem Labs Dec-qtr Profit Rises

* DEC QUARTER PROFIT 25.07 BILLION RUPEES VERSUS 261.1 MILLION RUPEES YEAR AGO

BRIEF-Unichem Laboratories To Consider Proposal To Buy-Back Shares Of Co

* SAYS TO CONSIDER PROPOSAL TO BUY-BACK SHARES OF CO Source text - http://bit.ly/2CxeEdf Further company coverage:

BRIEF-Torrent Pharma Completes Acquisition Of Branded Formulation Business Of Unichem Labs

* SAYS TORRENT PHARMACEUTICALS LIMITED COMPLETES ACQUISITION OF BRANDED FORMULATION BUSINESS OF UNICHEM LABORATORIES LIMITED Source text: http://bit.ly/2krSQVo Further company coverage:

Torrent Pharma to buy Unichem Labs' India business for $558 million

Torrent Pharmaceuticals said on Friday it would buy more than 120 brands from Unichem Laboratories in India and Nepal, and its manufacturing plant at Sikkim.

Torrent Pharma to buy Unichem Labs' India business for $558 mln

Torrent Pharmaceuticals said on Friday it would buy more than 120 brands of Unichem Laboratories in India and Nepal and its manufacturing plant at Sikkim.

BRIEF-‍Torrent Pharma buys branded business of India & Nepal from Unichem

* Torrent Pharma acquires branded formulation business of India and Nepal of Unichem Laboratories Limited

BRIEF-India's Unichem Laboratories Sept-qtr profit rises

* Sept quarter profit 458.2 million rupees versus profit of 205.2 million rupees year ago

BRIEF-Unichem Labs gets ANDA approval for Irbesartan and hydrochlorothiazide tablets

* Says gets ANDA approval from USFDA for irbesartan and hydrochlorothiazide tablets usp Source text for Eikon: Further company coverage:

BRIEF-India's Unichem Labs June-qtr profit falls

* June quarter profit 15 million rupees versus 257.7 million rupees year ago

BRIEF-Unichem Laboratories gets ANDA approval from USFDA for hypertension treating tablets

* Says receives anda approval from usfda for Losartan potassium and hydrochlorothiazide tablets USP

BRIEF-Unichem Labs gets EIR from USFDA for co's manufacturing facility at Goa

* Receipt of EIR from United States Food And Drug Administration for company's manufacturing facility at Goa

BRIEF-Unichem Labs gets EIR from U.S. FDA for Ghaziabad facility

* Co's formulations manufacturing facility at Ghaziabad has received an Establishment Inspection Report (EIR) from U.S. FDA

BRIEF-India's Unichem Labs March-qtr profit rises

* March quarter profit 314.6 million rupees versus 276.9 million rupees year ago

BRIEF-Unichem Labs gets FDA nod for migraine drug

* Says receives ANDA approval from USFDA for rizatriptan benzoate odt & rizatriptan benzoate tablets USP

BRIEF-Unichem Labs says FDA issues 2 observations for co's Ghaziabad facility

* Says formulation manufacturing faciility at Ghaziabad inspected by USFDA

BRIEF-Unichem Labs Sept-qtr profit falls

* Sept-qtr net profit 205.2 million rupees versus 231.3 million rupees year ago

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up